WHO confirms there is no existing scientific evidence linking ibuprofen and the worsening of COVID-19 symptoms

The World Health Organization (WHO) reacted on its social media following recent claims that non-steroidal anti-inflammatories (NSAIDs), such as ibuprofen, could worsen disease for people with COVID-19. Stating that “based on currently available information, WHO does not recommend against the use of ibuprofen”, WHO further adds that they are consulting with physicians treating the patients and are not aware of reports of any negative effects, beyond the usual ones that limit its use in certain populations.

This statement echoes the previously released EMA’s advice on the use of non-steroidal anti-inflammatories for COVID-19, which recommends that patients and healthcare professionals should consider all available treatment options including paracetamol and NSAIDs (like ibuprofen) in the treatment of COVID-19 infection. In line with EU national treatment guidelines, patients and healthcare professionals can continue using NSAIDs as per the approved product information. Current advice includes that these medicines are used at the lowest effective dose for the shortest possible period.

The Association of the European Self-Care Industry (AESGP) welcomes this statement, as it gives further clarity on this important topic. Responsible self-care is crucial in decreasing the burden on health-care systems, particularly during this time of crisis. Combatting myth and misinformation has never been so important. Patients are to be supported with transparent and validated information from official sources and authorities.